| pubmed-article:17054930 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17054930 | lifeskim:mentions | umls-concept:C0018823 | lld:lifeskim |
| pubmed-article:17054930 | lifeskim:mentions | umls-concept:C0086045 | lld:lifeskim |
| pubmed-article:17054930 | lifeskim:mentions | umls-concept:C0680730 | lld:lifeskim |
| pubmed-article:17054930 | lifeskim:mentions | umls-concept:C0541315 | lld:lifeskim |
| pubmed-article:17054930 | lifeskim:mentions | umls-concept:C1707455 | lld:lifeskim |
| pubmed-article:17054930 | lifeskim:mentions | umls-concept:C1510438 | lld:lifeskim |
| pubmed-article:17054930 | lifeskim:mentions | umls-concept:C1148554 | lld:lifeskim |
| pubmed-article:17054930 | lifeskim:mentions | umls-concept:C1174751 | lld:lifeskim |
| pubmed-article:17054930 | pubmed:issue | 12 | lld:pubmed |
| pubmed-article:17054930 | pubmed:dateCreated | 2006-12-12 | lld:pubmed |
| pubmed-article:17054930 | pubmed:abstractText | Therapeutic monitoring of everolimus with chromatographic methods (HPLC) enabled effective immunosuppression while limiting the incidence of drug-related adverse events. A fluorescence polarization immunoassay (FPIA) has been recently developed for the assessment of everolimus levels. The present study was designed to evaluate FPIA performance and to compare it to HPLC. | lld:pubmed |
| pubmed-article:17054930 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17054930 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17054930 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17054930 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17054930 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17054930 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17054930 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17054930 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:17054930 | pubmed:issn | 0009-9120 | lld:pubmed |
| pubmed-article:17054930 | pubmed:author | pubmed-author:JazínE EEE | lld:pubmed |
| pubmed-article:17054930 | pubmed:author | pubmed-author:PericoNorbert... | lld:pubmed |
| pubmed-article:17054930 | pubmed:author | pubmed-author:FiocchiRobert... | lld:pubmed |
| pubmed-article:17054930 | pubmed:author | pubmed-author:OttomanoCosim... | lld:pubmed |
| pubmed-article:17054930 | pubmed:author | pubmed-author:MerliniSimona... | lld:pubmed |
| pubmed-article:17054930 | pubmed:author | pubmed-author:BaldelliSaraS | lld:pubmed |
| pubmed-article:17054930 | pubmed:author | pubmed-author:CrippaAlberto... | lld:pubmed |
| pubmed-article:17054930 | pubmed:author | pubmed-author:GabrieliRober... | lld:pubmed |
| pubmed-article:17054930 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17054930 | pubmed:volume | 39 | lld:pubmed |
| pubmed-article:17054930 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17054930 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17054930 | pubmed:pagination | 1152-9 | lld:pubmed |
| pubmed-article:17054930 | pubmed:meshHeading | pubmed-meshheading:17054930... | lld:pubmed |
| pubmed-article:17054930 | pubmed:meshHeading | pubmed-meshheading:17054930... | lld:pubmed |
| pubmed-article:17054930 | pubmed:meshHeading | pubmed-meshheading:17054930... | lld:pubmed |
| pubmed-article:17054930 | pubmed:meshHeading | pubmed-meshheading:17054930... | lld:pubmed |
| pubmed-article:17054930 | pubmed:meshHeading | pubmed-meshheading:17054930... | lld:pubmed |
| pubmed-article:17054930 | pubmed:meshHeading | pubmed-meshheading:17054930... | lld:pubmed |
| pubmed-article:17054930 | pubmed:meshHeading | pubmed-meshheading:17054930... | lld:pubmed |
| pubmed-article:17054930 | pubmed:year | 2006 | lld:pubmed |
| pubmed-article:17054930 | pubmed:articleTitle | Comparison of the Innofluor certican assay with HPLC-UV for the determination of everolimus concentrations in heart transplantation. | lld:pubmed |
| pubmed-article:17054930 | pubmed:affiliation | Department of Medicine and Transplantation, Ospedali Riuniti di Bergamo-Mario Negri Institute for Pharmacological Research, Bergamo, Italy. | lld:pubmed |
| pubmed-article:17054930 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17054930 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:17054930 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:17054930 | pubmed:publicationType | Evaluation Studies | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17054930 | lld:pubmed |
